If you have a type of biopsy-confirmed kidney disease called focal segmental glomerulosclerosis (FSGS), a clinical research study may be an option for you.
We are looking for adults of African, Caribbean, or Latin American descent between the ages of 18 and 65 with a type of kidney disease called FSGS who also have specific changes in the apolipoprotein L1 (APOL1) gene to participate in this clinical research study. Specific changes in the APOL1 gene have been shown to contribute to FSGS disease progression. These changes can run in families and are typically present in individuals of African, Caribbean, or Latin American descent. Testing for the APOL1 gene is included in this clinical study. If you are interested in taking part, please continue below and complete the questionnaire to determine your eligibility.
Learn more about this study.
This website uses Secure Socket Layer technology and encryption methods to protect personal health information. If you’d like to know more about this, click here.
Enter your zip code below or click on the map to find the participating research site(s) nearest you.
Active site locations Potential site locations